Quest diagnostics and paige form collaboration to advance ai-generated pathology insights to improve cancer diagnosis and care

Secaucus, n.j. and new york, may 25, 2021 /prnewswire/ -- quest diagnostics (nyse:dgx) and paige today announced a collaboration designed to unlock the potential of artificial intelligence (ai) to improve and speed the diagnosis of cancer and other diseases that rely on pathologic assessment.
DGX Ratings Summary
DGX Quant Ranking